Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Lymphoid 2Other hematologic neoplasm 1Myeloid 1

Conditions

Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Hodgkin Disease 2Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, Mantle-Cell 1Leukemia, Myeloid, Acute 1Leukemia 1

Interventions

fludarabine phosphate 90Cyclophosphamide 85Mycophenolic Acid 67Peripheral Blood Stem Cell Transplantation 65Whole-Body Irradiation 59Tacrolimus 58Cyclosporine 46Busulfan 45Antilymphocyte Serum 39fludarabine 35Filgrastim 35Melphalan 33Methotrexate 28Radiotherapy 26Granulocyte Colony-Stimulating Factor 20Sirolimus 17Methylprednisolone 17Etoposide 17Cord Blood Stem Cell Transplantation 17Rituximab 14Stem Cell Transplantation 13Alemtuzumab 13thymoglobulin 11sargramostim 11Cyclosporins 11Therapeutics 10Flow Cytometry 10Cytarabine 10plerixafor 8Thiotepa 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hodgkin Disease × Leuprolide × Plasma cell × Clear all
NCT01343368 2017-12-05

Preservation of Ovarian Function After Hematopoietic Cell Transplant

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
19 enrolled 19 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

NCT00275262 2010-05-06

A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation

Abbott

Phase 2 Terminated
25 enrolled 12 charts
LymphoidPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡